Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Eilean Therapeutics
Eilean Therapeutics
University of Alabama at Birmingham
Incyte Corporation
Incyte Corporation
Incyte Corporation
Prelude Therapeutics
iOnctura
City of Hope Medical Center
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Chicago
Stanford University
City of Hope Medical Center
Mayo Clinic
Hangzhou GluBio Pharmaceutical Co., Ltd.
AbbVie
American Regent, Inc.
University of Virginia
Cellenkos, Inc.
Icahn School of Medicine at Mount Sinai
AbbVie
Epigenetix, Inc.
Astex Pharmaceuticals, Inc.
Vanderbilt-Ingram Cancer Center
Fox Chase Cancer Center
Newave Pharmaceutical Inc
City of Hope Medical Center
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center
AbbVie
Herlev Hospital
Lynk Pharmaceuticals Co., Ltd
Prelude Therapeutics
Icahn School of Medicine at Mount Sinai
Roswell Park Cancer Institute
Taiga Biotechnologies, Inc.
University of Rochester
Medigene AG
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Novartis
Tarix Pharmaceuticals
Case Comprehensive Cancer Center
Daiichi Sankyo